A comparison of fluorescence in situ hybridization (FISH) and cytogenetics for detection of CSF1 (1p13) rearrangements in tenosynovial giant cell tumors

被引:0
|
作者
Nishio, J. [1 ]
Neff, J. R. [1 ]
Dafferner, A. J. [1 ]
Hartmann, M. M. [1 ]
Zhou, M. [1 ]
Bridge, J. A. [1 ]
机构
[1] Univ Nebraska, Med Ctr, Omaha, NE USA
来源
JOURNAL OF MOLECULAR DIAGNOSTICS | 2006年 / 8卷 / 05期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:659 / 659
页数:1
相关论文
共 50 条
  • [31] Correlation of fluorescence in situ hybridization (FISH) of formalin-fixed tissue with RT-PCR and/or cytogenetics in the detection of rearrangements of the FKHR(13q14) gene in alveolar rhabdomyosarcoma
    Downs-Kelly, E
    Lopez-Terrada, D
    Hartke, M
    Goldblum, J
    Tubbs, R
    Skacel, M
    MODERN PATHOLOGY, 2006, 19 : 11A - 11A
  • [32] Correlation of fluorescence in situ hybridization (FISH) of formalin-fixed tissue with RT-PCR and/or cytogenetics in the detection of rearrangements of the FKHR(13q14) gene in alveolar rhabdomyosarcoma
    Downs-Kelly, E
    Lopez-Terrada, D
    Hartke, M
    Goldblum, J
    Tubbs, R
    Skacel, M
    LABORATORY INVESTIGATION, 2006, 86 : 11A - 11A
  • [33] Cytogenetic and fluorescence in situ hybridization characterization of chromosome 1 rearrangements in head and neck carcinomas delineate a target region for deletions within 1p11-1p13
    Jin, YS
    Jin, C
    Wennerberg, J
    Mertens, F
    Höglund, M
    CANCER RESEARCH, 1998, 58 (24) : 5859 - 5865
  • [34] ALK and ROS1 gene rearrangements detected in colorectal cancer (CRC) by fluorescence in situ hybridization (FISH)
    Weickhardt, Andrew James
    Nguyen, Teresa T.
    Paskulin, Diego D.
    Le, Anh T.
    Aisner, Dara
    Schulte, Nathan
    Chionh, Fiona J. M.
    Mariadason, John
    Tebbutt, Niall C.
    Doebele, Robert Charles
    Varella-Garcia, Marileila
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Loss of 1p in recurrent meningiomas:: a comparative study in successive recurrences by cytogenetics and fluorescence in situ hybridization
    López-Ginés, C
    Cerdá-Nicolás, M
    Gil-Benso, R
    Barcia-Salorio, JL
    Llombart-Bosch, A
    CANCER GENETICS AND CYTOGENETICS, 2001, 125 (02) : 119 - 124
  • [36] Nasopharyngeal hyalinizing clear cell carcinoma with EWSR1 rearrangements diagnosed by fluorescence in situ hybridization
    Fukuda, Atsushi
    Tagami, Yohei
    Takasawa, Akira
    Sugita, Shintaro
    Kuramoto, Rinnosuke
    Imai, Suguru
    Hasegawa, Tadashi
    Iizuka, Keiji
    AURIS NASUS LARYNX, 2015, 42 (05) : 412 - 415
  • [37] Diffuse-type Tenosynovial Giant Cell Tumor with t(1;17)(p13;p13) and Trisomy 5
    Nishi, Jun
    Kamachi, Yuki
    Iwasaki, Hiroshi
    Naito, Masatoshi
    IN VIVO, 2014, 28 (05): : 949 - 952
  • [38] Chromosomes 1 and 12 abnormalities in pediatric germ cell tumors by interphase fluorescence in situ hybridization
    Bussey, KJ
    Lawce, HJ
    Himoe, E
    Shu, XO
    Suijkerbuijk, RF
    Olson, SB
    Magenis, RE
    CANCER GENETICS AND CYTOGENETICS, 2001, 125 (02) : 112 - 118
  • [39] Detection of p16 gene deletions in gliomas: A comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR
    Perry, A
    Nobori, T
    Ru, N
    Anderl, K
    Borell, TJ
    Mohapatra, G
    Feuerstein, BG
    Jenkins, RB
    Carson, DA
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (09): : 999 - 1008
  • [40] CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of Vimseltinib
    Gelderblom, Hans
    Razak, Albiruni A.
    Taylor, Matthew H.
    Bauer, Todd M.
    Wilky, Breelyn
    Martin-Broto, Javier
    Gonzalez, Alejandro F.
    Rutkowski, Piotr
    Szostakowski, Bartlomiej
    Alcindor, Thierry
    Saleh, Ramy
    Genta, Sofia
    Stacchiotti, Silvia
    van de Sande, Michiel
    Wagner, Andrew J.
    Bernthal, Nicholas
    Davis, Lara E.
    Vuky, Jacqueline
    Tait, Christopher
    Matin, Bahar
    Narasimhan, Supraja
    Sharma, Maitreyi G.
    Ruiz-Soto, Rodrigo
    Sherman, Matthew L.
    Tap, William D.
    CLINICAL CANCER RESEARCH, 2024, 30 (18) : 3996 - 4004